One of the key presentations at the 2018 Pharmacovigilance and Drug Safety Summit in Berlin was from Dr. Sameer Thapar, Global Pharmacovigilance Director at Oracle Health Sciences Consulting, who gave two forward-thinking presentations about the use of cloud computing and artificial intelligence in pharmacovigilance.
With more than 60% of drug safety experts planning to use AI to improve processes, we’ll share why the general interest in AI is growing and how the industry has embraced other technologies such as the role of big data and cloud computing.
Here are some key learnings from Dr. Thapar’s presentation about merging these technologies and how they’re being used within PV and drug safety.
This content is restricted to site members. If you are an existing user, please log in. New users may register below.